BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 1582070)

  • 1. Diagnostic and prognostic significance of different antinuclear antibodies in more than 1000 consecutive Albanian patients with rheumatic diseases.
    Sulcebe G; Morcka K
    Clin Exp Rheumatol; 1992; 10(3):255-61. PubMed ID: 1582070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low diagnostic and predictive value of anti-dsDNA antibodies in unselected patients with recent onset of rheumatic symptoms: results from a long-term follow-up Scandinavian multicentre study.
    Compagno M; Jacobsen S; Rekvig OP; Truedsson L; Heegaard NH; Nossent J; Jönsen A; Jacobsen RS; Eilertsen GØ; Sturfelt G; Bengtsson AA
    Scand J Rheumatol; 2013; 42(4):311-6. PubMed ID: 23496224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
    Yang Z; Ren Y; Liu D; Lin F; Liang Y
    APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of anti-Sm, anti-RNP, anti-Ro/SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus.
    Sánchez-Guerrero J; Lew RA; Fossel AH; Schur PH
    Arthritis Rheum; 1996 Jun; 39(6):1055-61. PubMed ID: 8651971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing.
    Tipu HN; Bashir MM
    J Coll Physicians Surg Pak; 2018 Jan; 28(1):40-43. PubMed ID: 29290190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
    Faria AC; Barcellos KS; Andrade LE
    J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to the extractable nuclear antigens (ENA) in Pakistani patients with systemic rheumatic disease.
    Ahmed TA; Malik IA; Saleem M; Khan AA; Hameed A; Shah ST; Amin SJ; Farooqi A
    J Pak Med Assoc; 1995 Jan; 45(1):12-4. PubMed ID: 7731078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modern look at the problems of investigation of antinuclear antibodies in systemic lupus erythematosus (literature review).].
    Aleksandrova EN; Verizhnikova ZG; Novikov AA; Lukina GV
    Klin Lab Diagn; 2018; 63(6):340-348. PubMed ID: 30702224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinuclear antibody testing. A study of clinical utility.
    Slater CA; Davis RB; Shmerling RH
    Arch Intern Med; 1996 Jul; 156(13):1421-5. PubMed ID: 8678710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical value of multiplex immune assay of antinuclear antibodies in systemic lupus erythematosus.].
    Aleksandrova EN; Verizhnikova ZG; Novikov AA; Panafidina TA; Popkova TV; Lukina GV
    Klin Lab Diagn; 2018; 63(7):434-438. PubMed ID: 30720960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Theoretical objective evaluation of the value of a diagnostic criterion. Application to antinuclear antibodies for the diagnosis of systemic lupus erythematosus].
    Vinceneux P; Yeni P; Boboc B; Carbon C
    Rev Rhum Mal Osteoartic; 1984 Oct; 51(9):493-6. PubMed ID: 6334353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal anti-nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent-onset disease.
    Frodlund M; Wetterö J; Dahle C; Dahlström Ö; Skogh T; Rönnelid J; Sjöwall C
    Clin Exp Immunol; 2020 Mar; 199(3):245-254. PubMed ID: 31778219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
    Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
    J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of antinuclear antibody tests in children.
    McGhee JL; Kickingbird LM; Jarvis JN
    BMC Pediatr; 2004 Jul; 4():13. PubMed ID: 15245579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases.
    Clegg DO; Williams HJ; Singer JZ; Steen VD; Schlegel S; Ziminski C; Alarcón GS; Luggen ME; Polisson RP; Willkens RF
    J Rheumatol; 1991 Sep; 18(9):1340-3. PubMed ID: 1757935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of anti-nuclear antibody by immunofluorescence assay and enzyme immunoassay in childhood systemic lupus erythematosus: experience from Bangladesh.
    Dipti TR; Azam MS; Sattar MH; Rahman SA
    Int J Rheum Dis; 2012 Feb; 15(1):121-5. PubMed ID: 22324956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to extractable nuclear antigens (ENAS) in systemic lupus erythematosus patients: correlations with clinical manifestations and disease activity.
    Emad Y; Gheita T; Darweesh H; Klooster P; Gamal R; Fathi H; El-Shaarawy N; Gamil M; Hawass M; El-Refai RM; Al-Hanafi H; Abd-Ellatif S; Ismail A; Rasker J
    Reumatismo; 2018 Jul; 70(2):85-91. PubMed ID: 29976042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of anti-nDNA antibodies in ANA-positive systemic lupus erythematosus: comparison of the Farr radioimmunoassay and the Crithidia luciliae immunofluorescent technique.
    Chuan MT; Wu YC; Ang ET; Wang JH; In KL; Lü YC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Feb; 18(1):15-24. PubMed ID: 3896689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic.
    Vlachoyiannopoulos PG; Tzavara V; Dafni U; Spanos E; Moutsopoulos HM
    J Rheumatol; 1998 May; 25(5):886-91. PubMed ID: 9598885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.